Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 4374375, 12 pages
http://dx.doi.org/10.1155/2016/4374375
Research Article

Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection

1Department of Microbiology, Ajou University School of Medicine, Suwon, Republic of Korea
2Department of Applied Chemistry and Biological Engineering, Ajou University, Suwon, Republic of Korea
3Department of Biomedical Sciences, Ajou University, Suwon, Republic of Korea

Received 20 July 2016; Accepted 12 October 2016

Academic Editor: Teresa Zelante

Copyright © 2016 Bunsoon Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z.-S. Wen, Y.-L. Xu, X.-T. Zou, and Z.-R. Xu, “Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice,” Marine Drugs, vol. 9, no. 6, pp. 1038–1055, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Knorr, “Use of chitinous polymers in food: a challenge for food research and development,” Food Technology, vol. 38, no. 1, pp. 85–97, 1984. View at Google Scholar
  3. K. Kurita, “Chemistry and application of chitin and chitosan,” Polymer Degradation and Stability, vol. 59, no. 1–3, pp. 117–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Razdan and D. Pettersson, “Effect of chitin and chitosan on nutrient digestibility and plasma lipid concentrations in broiler chickens,” British Journal of Nutrition, vol. 72, no. 2, pp. 277–288, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. H. K. No, N. Y. Park, S. H. Lee, and S. P. Meyers, “Antibacterial activity of chitosans and chitosan oligomers with different molecular weights,” International Journal of Food Microbiology, vol. 74, no. 1-2, pp. 65–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. X. R. Zhao and W. S. Xia, “Antimicrobial activities of chitosan and application in food preservation,” Chinese Food Research and Development, vol. 27, no. 2, pp. 157–160, 2006. View at Google Scholar
  7. S.-K. Kim and N. Rajapakse, “Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review,” Carbohydrate Polymers, vol. 62, no. 4, pp. 357–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Zhou, W. Xia, C. Zhang, and L. (Lucy) Yu, “In vitro binding of bile acids and triglycerides by selected chitosan preparations and their physico-chemical properties,” LWT—Food Science and Technology, vol. 39, no. 10, pp. 1087–1092, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Bravo-Osuna, G. Millotti, C. Vauthier, and G. Ponchel, “In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles,” International Journal of Pharmaceutics, vol. 338, no. 1-2, pp. 284–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, “Targeted delivery of low molecular drugs using chitosan and its derivatives,” Advanced Drug Delivery Reviews, vol. 62, no. 1, pp. 28–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Zaharoff, C. J. Rogers, K. W. Hance, J. Schlom, and J. W. Greiner, “Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination,” Vaccine, vol. 25, no. 11, pp. 2085–2094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Highton, T. Kojarunchitt, A. Girardin, S. Hook, and R. A. Kemp, “Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma,” Immunology and Cell Biology, vol. 93, no. 7, pp. 634–640, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-Y. Yeh, Y.-L. Shih, H.-Y. Chung et al., “Chitosan promotes immune responses, ameliorates glutamic oxaloacetic transaminase and glutamic pyruvic transaminase, but enhances lactate dehydrogenase levels in normal mice in vivo,” Experimental and Therapeutic Medicine, vol. 11, no. 4, pp. 1300–1306, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Nishimura, S. Nishimura, N. Nishi, I. Saiki, S. Tokura, and I. Azuma, “Immunological activity of chitin and its derivatives,” Vaccine, vol. 2, no. 1, pp. 93–99, 1984. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Nishimura, C. Ishihara, S. Ukei, S. Tokura, and I. Azuma, “Stimulation of cytokine production in mice using deacetylated chitin,” Vaccine, vol. 4, no. 3, pp. 151–156, 1986. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Marcinkiewicz, A. Poewska, and J. Knapczyk, “Immunoadjuvant properties of chitosan,” Archivum Immunologiae et Therapiae Experimentalis, vol. 39, no. 1-2, pp. 127–132, 1991. View at Google Scholar · View at Scopus
  17. L. R. Stanberry, “Pathogenesis of herpes simplex virus infection and animal models for its study,” Current Topics in Microbiology and Immunology, vol. 179, pp. 15–30, 1992. View at Google Scholar · View at Scopus
  18. R. J. Whitley, D. W. Kimberlin, and B. Roizman, “Herpes simplex viruses,” Clinical Infectious Diseases, vol. 26, no. 3, pp. 541–555, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Caspary, B. Schindling, S. Dundarov, and D. Falke, “Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2,” Archives of Virology, vol. 65, no. 3-4, pp. 219–227, 1980. View at Publisher · View at Google Scholar · View at Scopus
  20. R. H. Bonneau, J. F. Sheridan, N. Feng, and R. Glaser, “Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to herpes simplex virus infection,” Brain, Behavior, and Immunity, vol. 5, no. 3, pp. 274–295, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. A. L. Cunningham, R. R. Turner, A. C. Miller, M. F. Para, and T. C. Merigan, “Evolution of recurrent herpes simplex lesions. An Immunohistologic Study,” Journal of Clinical Investigation, vol. 75, no. 1, pp. 226–233, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. D. M. Koelle, C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey, “Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes,” The Journal of Clinical Investigation, vol. 101, no. 7, pp. 1500–1508, 1998. View at Publisher · View at Google Scholar
  23. J. T. Schiffer, L. Abu-Raddad, K. E. Mark et al., “Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 44, pp. 18973–18978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Mikloska and A. L. Cunningham, “Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes,” Journal of General Virology, vol. 79, no. 2, pp. 353–361, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Mikloska and A. L. Cunningham, “Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission,” Journal of Virology, vol. 75, no. 23, pp. 11821–11826, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kim, N. R. Osborne, W. Zeng et al., “Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes,” Journal of Immunology, vol. 188, no. 9, pp. 4158–4170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Choi, J. Y. Choi, D. H. Jo, and S. Sohn, “Oral delivery of DNA vector conjugated with chitosan and its effect on th1 polarized inflammation,” in Advances in the Diagnosis and Treatment of Vasculitis, Advances in Immunoassay Technology, chapter 12, pp. 221–232, 2011. View at Google Scholar
  28. M. Tanaka, H. Kodaira, Y. Nishiyama, T. Sata, and Y. Kawaguchi, “Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes,” Microbes and Infection, vol. 6, no. 5, pp. 485–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-K. Park, C. Choi, J.-P. Nam et al., “Preparation and characterization of highly pured water-soluble chitosan oligosaccharides as biomaterials,” Polymer (Korea), vol. 38, no. 1, pp. 85–92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Sohn, E.-S. Lee, D. Bang, and S. Lee, “Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice,” European Journal of Dermatology, vol. 8, no. 1, pp. 21–23, 1998. View at Google Scholar · View at Scopus
  31. N. Sato, H. J. Patel, T. A. Waldmann, and Y. Tagaya, “The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells,” Proceedings of the National Academy of Sciences, vol. 104, no. 2, pp. 588–593, 2007. View at Google Scholar
  32. C.-H. Shen, Q. Ge, O. Talay, H. N. Eisen, A. García-Sastre, and J. Chen, “Loss of IL-7R and IL-15R expression is associated with disappearance of memory T cells in respiratory tract following influenza infection,” Journal of Immunology, vol. 180, no. 1, pp. 171–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Landmann, B. Müller, and W. Zimmerli, “CD14, new aspects of ligand and signal diversity,” Microbes and Infection, vol. 2, no. 3, pp. 295–304, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Haziot, B.-Z. Tsuberi, and S. M. Goyert, “Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-α in response to lipopolysaccharide,” The Journal of Immunology, vol. 150, no. 12, pp. 5556–5565, 1993. View at Google Scholar · View at Scopus
  35. M. C. Dessing, K. F. van der Sluijs, S. Florquin, and T. van der Poll, “CD14 plays a limited role during influenza A virus infection in vivo,” Immunology Letters, vol. 113, no. 1, pp. 47–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. K.-H. Lue, R. P. Lauener, R. J. Winchester, R. S. Geha, and D. Vercelli, “Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells,” Journal of Immunology, vol. 147, no. 4, pp. 1134–1138, 1991. View at Google Scholar · View at Scopus
  37. J. E. Rey Nores, A. Bensussan, N. Vita et al., “Soluble CD14 acts as a negative regulator of human T cell activation and function,” European Journal of Immunology, vol. 29, no. 1, pp. 265–276, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. R. M. Steinman and H. Hemmi, “Dendritic cells: translating innate to adaptive immunity,” Current Topics in Microbiology and Immunology, vol. 311, pp. 17–58, 2006. View at Google Scholar · View at Scopus
  39. M. Colonna, B. Pulendran, and A. Iwasaki, “Dendritic cells at the host-pathogen interface,” Nature Immunology, vol. 7, no. 2, pp. 117–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Pulendran, H. Tang, and T. L. Denning, “Division of labor, plasticity, and crosstalk between dendritic cell subsets,” Current Opinion in Immunology, vol. 20, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. J. Allen, K. R. Mott, A. A. Chentoufi et al., “CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection,” Journal of Virology, vol. 85, no. 19, pp. 9945–9955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Scott and G. Trinchieri, “The role of natural killer cells in host-parasite interactions,” Current Opinion in Immunology, vol. 7, no. 1, pp. 34–40, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. G. J. Bancroft, “The role of natural killer cells in innate resistance to infection,” Current Opinion in Immunology, vol. 5, no. 4, pp. 503–510, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. P. C. Reading, P. G. Whitney, D. P. Barr, M. J. Smyth, and A. G. Brooks, “NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection,” European Journal of Immunology, vol. 36, no. 4, pp. 897–905, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Kambayashi, E. Assarsson, B. J. Chambers, and H.-G. Ljunggren, “Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection,” European Journal of Immunology, vol. 31, no. 5, pp. 1523–1530, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Hashido and T. Kawana, “Herpes simplex virus-specific IgM, IgA and IgG subclass antibody responses in primary and nonprimary genital herpes patients,” Microbiology and Immunology, vol. 41, no. 5, pp. 415–420, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Page, J. Taylor, R. L. Tideman et al., “Is HSV serology useful for the management of first episode genital herpes?” Sexually Transmitted Infections, vol. 79, no. 4, pp. 276–279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Li, “Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus,” Virology Journal, vol. 7, no. 1, pp. 125–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Kohl, “Herpes simplex virus immunology: problems, progress, and promises,” Journal of Infectious Diseases, vol. 152, no. 3, pp. 435–440, 1985. View at Publisher · View at Google Scholar · View at Scopus
  50. J. S. Pepose, “Herpes simplex keratitis: role of viral infection versus immune response,” Survey of Ophthalmology, vol. 35, no. 5, pp. 345–352, 1991. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Lopez and R. J. O'Reilly, “Cell mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay,” The Journal of Immunology, vol. 118, no. 3, pp. 895–902, 1977. View at Google Scholar · View at Scopus
  52. L. Rasmussen and T. C. Merigan, “Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 8, pp. 3957–3961, 1978. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Malmgaard, J. Melchjorsen, A. G. Bowie, S. C. Mogensen, and S. R. Paludan, “Viral activation of macrophages through TLR-dependent and -independent pathways,” Journal of Immunology, vol. 173, no. 11, pp. 6890–6898, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Dubois, J. Mariner, T. A. Waldmann, and Y. Tagaya, “IL-15Rα recycles and presents IL-15 in trans to neighboring cells,” Immunity, vol. 17, no. 5, pp. 537–547, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. M.-E. Janelle and L. Flamand, “Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6,” Archives of Virology, vol. 151, no. 8, pp. 1603–1614, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. L. M. Haynes, D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, and R. A. Tripp, “Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus,” Journal of Virology, vol. 75, no. 22, pp. 10730–10737, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. I. M. van der Lubben, J. C. Verhoef, G. Borchard, and H. E. Junginger, “Chitosan for mucosal vaccination,” Advanced Drug Delivery Reviews, vol. 52, no. 2, pp. 139–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. W. P. Halford, J. L. Maender, and B. M. Gebhardt, “Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1,” Virology Journal, vol. 2, article no. 56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. G. C. Koo and J. R. Peppard, “Establishment of monoclonal anti-Nk-1.1 antibody,” Hybridoma, vol. 3, no. 3, pp. 301–303, 1984. View at Publisher · View at Google Scholar · View at Scopus